127 related articles for article (PubMed ID: 713202)
1. [ The clinical and pathological study of bladder cancer. I. Immune evaluation with skin testing (author's transl)].
Imai Y
Nihon Hinyokika Gakkai Zasshi; 1978 Aug; 69(8):1035-43. PubMed ID: 713202
[No Abstract] [Full Text] [Related]
2. Immune response in bladder cancer patients.
Brosman S; Elhilali M; Vescera C; Fahey J
J Urol; 1979 Feb; 121(2):162-9. PubMed ID: 423328
[No Abstract] [Full Text] [Related]
3. [A study on cellular immunity in bladder cancer, with special reference to leukocyte adherence (author's transl)].
Shinka T
Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):495-503. PubMed ID: 381740
[No Abstract] [Full Text] [Related]
4. Immunological responsiveness in patients with bladder cancer.
Fahey JL; Brosman S; Dorey F
Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
[TBL] [Abstract][Full Text] [Related]
5. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
Lipenský R; Urban K
Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
[No Abstract] [Full Text] [Related]
6. [Value of DNFB skin testing in patients with bladder cancer (author's transl)].
Hudemann B; Seyfarth M
Arch Geschwulstforsch; 1980; 50(2):173-7. PubMed ID: 7436702
[TBL] [Abstract][Full Text] [Related]
7. Immunologic unreactivity in bladder cancer patients.
Olsson CA; Rao CN; Menzoian JO; Byrd WE
J Urol; 1972 Apr; 107(4):607-9. PubMed ID: 5014367
[No Abstract] [Full Text] [Related]
8. [Correlation of the immune profile with local immunocyte infiltration in urinary bladder tumours (author's transl)].
Flamm J; Burkert S
Urol Int; 1982; 37(1):61-7. PubMed ID: 7112760
[TBL] [Abstract][Full Text] [Related]
9. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
Flamm J; Burkert S
Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
[TBL] [Abstract][Full Text] [Related]
10. [Cell-mediated immunity in patients with non-lymphoid solid tumours. Correlation with tumour stage, response to therapy and survival (author's transl)].
Simo-Camps E; Anguera A; Vich JM; Vidal-Ribas A; Sala A; Sarrias R; Gumma J; Gri E; Puigdollers JM
Sangre (Barc); 1975; 20(2):177-83. PubMed ID: 1145396
[No Abstract] [Full Text] [Related]
11. [Unspecific cellular immunity in patients with bladder cancer].
Diem P; Studer U
Helv Chir Acta; 1982 Aug; 49(3-4):391-3. PubMed ID: 7129906
[No Abstract] [Full Text] [Related]
12. [Studies on the relationship between cellular immunologic activity and prognosis in patients with gynecologic malignancy (author's transl)].
Kawasaki H
Nihon Gan Chiryo Gakkai Shi; 1976 Jun; 11(2):209-17. PubMed ID: 987122
[No Abstract] [Full Text] [Related]
13. Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancer.
Pinsky CM; Wanebo H; Mike V; Oettgen H
Ann N Y Acad Sci; 1976; 276():407-10. PubMed ID: 1071969
[No Abstract] [Full Text] [Related]
14. Correlation between phytohemagglutinin skin test and delayed cutaneous hypersensitivity to dinitrochlorobenzene in cancer patients.
Sone S; Yata K; Tsubura E
Gan; 1976 Aug; 67(4):621-2. PubMed ID: 1024855
[No Abstract] [Full Text] [Related]
15. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
16. In vivo skin test in carcinoma bladder.
Gupta NP; Rajagopal V; Malaviya AN; Singh SM
Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):163-5. PubMed ID: 6545227
[No Abstract] [Full Text] [Related]
17. [Influence of T-lymphocytes in bladder cancer on appearance and infiltration of recurrences (author's transl)].
Stöber U
Urologe A; 1978 Sep; 17(5):296-302. PubMed ID: 309205
[TBL] [Abstract][Full Text] [Related]
18. Delayed cutaneous hypersensitivity ad peripheral blood lymphocyte counts in gastrointestinal cancer.
Gupta S; Seth SK; Udupa KN; Sen PC
Ann Acad Med Singap; 1980 Jan; 9(1):71-6. PubMed ID: 7447383
[TBL] [Abstract][Full Text] [Related]
19. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
[No Abstract] [Full Text] [Related]
20. [Cellular immunity in myasthenia gravis].
Mendes N; Kopersztych S; Saraiva S; de Assis JL
Rev Hosp Clin Fac Med Sao Paulo; 1978 Dec; 33(6):272-6. PubMed ID: 311506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
